Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 12 (Search time: 0.012 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancersChiam, K.; Ryan, N.; Ricciardelli, C.; Day, T.; Buchanan, G.; Ochnik, A.; Murti, K.; Selth, L.; Butler, L.; Tilley, W.; Bianco-Miotto, T.
2013Circulating microRNAs predict biochemical recurrence in prostate cancer patientsSelth, L.; Townley, S.; Bert, A.; Stricker, P.; Sutherland, P.; Horvath, L.; Goodall, G.; Butler, L.; Tilley, W.
2013Ex vivo culture of human prostate tissue and drug developmentCentenera, M.; Raj, G.; Knudsen, K.; Tilley, W.; Butler, L.
2013Ski-interacting protein (SKIP) interacts with androgen receptor in the nucleus and modulates androgen-dependent transcriptionAbankwa, D.; Millard, S.; Martel, N.; Choong, C.; Yang, M.; Butler, L.; Buchanan, G.; Tilley, W.; Ueki, N.; Hayman, M.; Leong, G.
2013Targeting cell cycle and hormone receptor pathways in cancerComstock, C.; Augello, M.; Goodwin, J.; de Leeuw, R.; Schiewer, M.; Ostrander, W.; Burkhart, R.; McClendon, A.; McCue, P.; Trabulsi, E.; Lallas, C.; Gomella, L.; Centenera, M.; Brody, J.; Butler, L.; Tilley, W.; Knudsen, K.
2013Identification of prostate cancer-associated microRNAs in circulation using a mouse model of diseaseSelth, L.; Townley, S.; Gillis, J.; Tilley, W.; Butler, L.
2013Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitorsGillis, J.; Selth, L.; Centenera, M.; Townley, S.; Sun, S.; Plymate, S.; Tilley, W.; Butler, L.
2013Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancerRavindranathan, P.; Lee, T.; Yang, L.; Centenera, M.; Butler, L.; Tilley, W.; Hsieh, J.; Ahn, J.; Raj, G.
2013SGTA: A new player in the molecular co-chaperone gamePhilp, L.; Butler, M.; Hickey, T.; Butler, L.; Tilley, W.; Day, T.
2013Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K/Akt signaling and inhibition of prostate cancer cell proliferationTrotta, A.; Need, E.; Selth, L.; Chopra, S.; Pinnock, C.; Leach, D.; Coetzee, G.; Butler, L.; Tilley, W.; Buchanan, G.